Liquid Biopsy Market Size, Share, Growth, Trends, and Global Industry Analysis: By Product Type (Consumables, Instruments) By Application Type (Blood, Urine Others) By Sample Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Liver Cancer Others) By End User (Hospitals, Diagnostic Laboratories, Academic and Research Centers Others) and Region

Liquid Biopsy Market size was valued at US$ 899.0 million in 2023 and is expected to reach US$ 2989.9 million by 2030, at a CAGR of 22.2% from 2024-2030. The market is gaining traction in recent times owing to its accurate, effective results in comparison with traditional cancer screening methods, which are achieved through minimal invasiveness and expenses. Challenges associated with traditional biopsies such as invasiveness, ill-informed results, post-sampling medical challenges, and costs are prompting healthcare professionals to adopt less invasive liquid biopsy tests for cancer screening and management, which is projected to create significant market demand for liquid biopsy products and services over the forecast period.

Moreover, several clinical research activities related to biomarkers are in the late stage and it is expected that upon successful launch and commercialization of these tests over the forecast period will result in significant market growth. This report studies market dynamics elaborately to identify the current trends & drivers, future opportunities, and possible challenges to the key stakeholders operating in the market. In addition, This report includes new product introductions; regulatory scenarios, and competition analyses with a vividly illustrated competition dashboard to assess the market competition.